Great news, there are now more sites for the Deucrictibant study in Melbourne.

We really need as many patients as possible to sign up for the study. This will help us ensure there are more treatment options available into the future for ALL.

Don’t forget you can be part of this study if you are on Prophylaxis treatment as long as you have the odd breakthrough attach AND it there is limited face to face appointments required and minimal journal keeping requirements.  This medication could be a total game changer for people who do not like needles or the additional responsibility they require when travelling etc. An Oral, acute care treatment is exactly what so many have been asking for for so long. 

Please see our Clinical Trials page here of see contact details below:

julia.lee1@monash.edu, emma.jackson1@monash.edu, and A/Professor Jason Fok (Primary Investigator for this study) jason.fok@monash.edu